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Abstract
Left ventricular (LV) lead positioning is one of the main contributors to the 
cardiac resynchronization therapy (CRT) response. Conventional left ventricular 
(LV) lead implantation faces several difficulties, which may ultimately affect 
lead stability and performance. Several imaging techniques have been proposed 
to overcome all these obstacles including multimodality cardiac imaging to help 
in preprocedural or intraprocedural identification of the latest activated areas of 
the LV. Emerging pacing strategies like LV multisite and multipoint pacing may 
help deliver an enhanced response to CRT, but prospective trials are warranted to 
confirm the superiority of this approach.
Keywords: cardiac resynchronization therapy, left ventricular lead implant, coronary 
sinus, coronary venous tree, left bundle branch block
1. Introduction
Cardiac resynchronization therapy (CRT) exerts its physiological effect by 
restoring the atrioventricular, interventricular, and intraventricular synchronicity. 
This in turn results in an enhancement in pumping efficiency. In addition, CRT 
leads to an improved left ventricular (LV) filling and, in some cases, a reduction 
in the mitral regurgitation. The beneficial effects of CRT translate in a majority of 
patients in an improved quality of life, increased exercise capacity, reduction in 
hospitalization for heart failure, and reduction in overall mortality [1–3].
In spite of all these advantages, a substantial minority (approximately 30%) of 
patients treated with CRT do not show clinical improvement [3, 4]. The reasons 
for non-response to CRT include: lack of LV dyssynchrony, non-optimal posi-
tion of the LV pacing lead, high-myocardial scar burden, and suboptimal device 
programming [5–10].
Given these considerations, the aim of this chapter was to review the different 
strategies of lead placement for CRT and their effect on clinical outcomes.
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2. Coronary venous anatomy
2.1 The structure of the coronary venous tree
Lead positioning for CRT depends to a great extent on the coronary venous 
anatomy, which indirectly can impact outcomes of cardiac resynchronization.
The coronary sinus (CS) is a venous conduit situated in the vicinity of the left 
atrioventricular (AV) groove, which continues the great cardiac vein (GCV) and 
empties into the right atrium (Figure 1) [11]. Although the CS is a constant land-
mark vein, its length and diameter are highly variable. The diameter of the CS var-
ies between 6 and 16 mm, while the diameter at its right atrial ostium can be from 
5 to 20 mm. Its length can vary from 2 to 5 cm [11]. The major tributaries entering 
the CS-GCV are the anterior interventricular vein (AIV), the middle cardiac vein 
(MCV), the left marginal veins, and the posterolateral vein of the LV.
The AIV ascends in the anterior interventricular sulcus adjacent to the left 
anterior descending coronary artery from the apex toward the base of the heart. It 
then courses laterally at the base of the heart, along the left atrioventricular groove 
to form the GCV. This vein drains blood from the apical region of the heart, the 
anterior surfaces of both ventricles, and the anterior interventricular septum and 
parts of the left atrium [11]. The MCV travels along the inferior region of the heart, 
in the posterior interventricular groove, parallel to the posterior descending coro-
nary artery [11]. The MCV drains the inferior walls of the ventricles, as well as the 
apical area and the posterior two-thirds of the septum. With an average diameter of 
4 mm, the MCV empties into the CS near its right atrial ostium.
A more recent classification of the elements of the CS tree is the segmental 
approach, which, by establishing a correlation between venous tributaries and 
segments of the left ventricle, allows a more precise placement of the LV lead for 
enhancing cardiac synchrony [12]. The CS body is segmented along a horizontal 
axis, from the CS ostium to the anterior interventricular groove into three equal 
zones (Figure 2).
Branches originating in each segment are labeled posterior, lateral, or anterior 
segmental branches. The LV is divided along the longitudinal axis into three equal 
segments: basal, mid, and apical. The length of the first-degree tributaries and the 
position of the second-degree tributaries were defined according to these segments. 
Figure 1. 
The coronary venous tree as seen on a rotational angiogram.
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This segmentation scheme also promotes potential optimization of the positioning 
of the LV lead along the lateral walls, framed by the network of second- and third-
order branches—optimization that becomes necessary in the absence of a suitable 
first-order segmental branch.
In most patients undergoing CRT, the target veins used for LV lead placement 
include the posterior, posterolateral, and marginal veins of the left ventricle. The 
number of left posterior veins may be from one to three, but usually, it is a single 
vein (60%). It empties into the CS in 75% of cases, but it can also terminate in 
the GCV. There are a few cases with no left posterior vein (5%), giving the place 
to the left marginal vein to drain the left ventricular posterolateral wall [11]. 
Usually, the left marginal vein is a tributary of the GCV (81%), but in approxi-
mately 19% of cases, it can drain directly into the CS. It is also named the obtuse 
marginal vein and drains much of the left ventricular myocardium.
2.2 Coronary venous imaging
The electrophysiologist should be aware of both the usual geometry of the 
coronary venous tree and also of the common variants and the alterations in 
geometry induced by the underlying cardiac pathology. A clear appreciation of 
these variations by a careful pre-implantation planning may help position the LV 
lead in an optimal position and thus allow for successful CRT. Methods used for 
preprocedural evaluation of CV anatomy include multislice computed tomography 
(CT) [13], electron beam CT, and the levophase of coronary angiography.
A major disadvantage for CT in evaluation for CRT lies in the fact that it cannot 
be repeated during interventions, its role being limited to preprocedural evaluation. 
Another limit may be the difficulty in visualizing second- and third-order tributar-
ies, details that are of paramount importance in optimal placing of the LV lead.
Figure 2. 
Coronary venogram in the LAO view illustrating the segmental approach to venous anatomy. From the base to 
the apex, the heart is divided along the long axis into basal, mid, and apical segments. In this LAO projection, 
branches originating in each segment were labeled posterior, lateral, or anterior segmental branches. The length 
of the first-degree tributaries and the position of the second-degree tributaries were defined according to these 
segments.
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The most commonly used method of imaging to facilitate the LV lead placement 
is intraprocedural CV angiography [11]. This technique requires cannulation of 
the coronary sinus, and a balloon occlusion catheter is placed in the proximal CS to 
impede the flow of blood. The contrast material is then injected to opacify the CV 
tree by retrograde filling, thus enabling the delineation of the venous anatomy in 
real time.
Standard coronary venous angiography (SCVA) defines coronary venous 
anatomy in two orthogonal static views that may lead to suboptimal delineation of 
the origin, angulations, and course of the venous tributaries. When compared to 
standard venography, high-speed rotational coronary venous angiography (RCVA) 
offers a multi-angle dynamic view of the CV tree, providing a three-dimensional 
perspective [11]. As described previously, RCVA uses a rapid 4-second isocentric 
rotation of the imaging camera over a 110° arc from a right anterior oblique 55° to 
left anterior oblique 55° [11]. The rotational images can then be reviewed over a full 
range of angles, providing the operator with a superior assessment regarding the 
coronary venous tree and its branches than standard images. RCVA showed promis-
ing steps toward obtaining the desired imaging quality, providing multiple visual-
ization angles, allowing for better identification, separation, and delimitation of the 
CS tree, all orders of segmental branches, as well as a more precise estimation of  
the take-off and angulation of its tributaries.
2.3 Variability of coronary venous anatomy in patients undergoing cardiac 
resynchronization therapy
During LV lead placement, knowledge of CS variations in morphology is of 
paramount importance as it may assist in the selection of the guiding catheter, 
leading to a successful CRT. The following anatomical features are important for CS 
cannulation: the CS ostial angle, the posterior displacement of the CS, the decrease 
in diameter at the junction between CS and great cardiac vein (GCV), the presence 
of stenoses and aneurysmal dilatations.
The CS ostial angle is acute in patients with severe tricuspid regurgitation and is 
more obtuse in patients with larger left atrial size [14].
While the CS is typically displaced from the left coronary sulcus toward the 
left atrium wall, the displacement is significantly more pronounced in patients 
post coronary artery bypass grafting (CABG) [15]. This, in turn, affects the shape 
of the GCV, accentuating its tortuosity, and thus, slowing or potentially stopping 
the advancement of the CS catheter during LV lead implant. Another potential 
obstruction of the CS cannulation may occur around the CS-GCV junction, in the 
form of a sudden diameter reduction in the area where the vein of Marshall takes 
off from the CS, as the latter continues as the GCV. The decrease in diameter of the 
vessel post junction appears to be greater in patients post CABG [15]. The interven-
tion seems to also affect the probability of encountering stenoses and aneurysmal 
dilatations of the CS, which are encountered in 5–10% of cases, predominantly 
post CABG (Figure 3).
Current practice involves LV lead placement targeting mainly posterior or 
lateral veins. Indeed, a study that analyzed RVCA images of 51 patients undergoing 
CRT reported successful identification of lateral veins in 91% of the patients and 
posterior veins in 76% of cases [11]. However, in terms of suitability for LV lead 
placement, characteristics such as diameter and take-off angles render many of the 
identified branches suboptimal for implant. Both posterior and lateral veins were 
tortuous in 15–30% of the patients undergoing CRT implant [11].
Another factor affecting the placement of the LV lead is the presence of myocar-
dial scar from prior myocardial infarctions (MIs). In a study by van de Veire et al., it 
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was shown that patients with a history of myocardial infarction (MI) are less likely 
to CS tributaries in the segments with scar [13].
3. Electrical activation of the failing heart
3.1 Electrical activation in patients with left bundle branch block
Left bundle branch block (LBBB) can be associated with conduction delay located 
at several anatomic levels in the conduction system from the distal His bundle to the 
left bundle branch and further distally to the arborization of the left bundle branch 
system [3]. In patients with LBBB and heart failure, the first ventricular site to be 
activated is the right ventricular (RV) free wall. The activation then proceeds to the 
right septum, and the latest RV site to be activated is the posterobasal region [16]. 
The first sites of the LV to be activated vary, but, most often these are located in the 
apical septum, and more rarely in the septobasal or midseptal region or in the anterior 
wall [17, 18]. In most patients, the activation spreads around the apex and across the 
inferior wall, in a “U-shaped” pattern, and reaches the anterolateral wall of the LV 
and then progresses toward the basal posterior or posterolateral wall [3, 17, 18].
The endocardial activation encompasses about 75% of the duration of the QRS 
complex [16]. The rest of the QRS is represented by the activation of the mid-
myocardium and epicardium [3, 18].
3.2 The electrical activation during CRT
During CRT, the RV and LV pacing leads generate two ventricular activation 
wavefronts, which move toward each other. If pacing is delivered with a sufficiently 
short AV delay, the left and right ventricular wavefronts merge before the intrinsic 
activation, conducted from the atria via the AV node, descends to the ventricles  
[3, 18–21]. The RV is depolarized entirely or almost entirely by the wavefront 
generated by the RV lead. The LV is activated from two sites: one situated in the 
interventricular septum initiated by the RV lead, and the other one situated onto the 
epicardial surface of the lateral LV initiated by the LV lead [17, 20, 22, 23].
Figure 3. 
Coronary sinus-great cardiac vein stenoses (green arrows) in patients with prior coronary artery bypass 
grafting.
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4. Lead placement for cardiac resynchronization therapy
4.1 LV anatomical positioning: interlead distance
In order to implant an LV pacing lead via a transvenous approach, the CS is can-
nulated and the LV lead is advanced toward a second- or third-order branch of the 
CS situated preferably on the anterolateral, lateral, posterior, or posterolateral LV 
wall (Figure 4) [3, 10, 15, 18, 23].
Achieving maximal anatomical and electrical separation between the right and 
left ventricular leads [23] may have a beneficial impact on clinical outcomes [10, 18].
The significance of the anatomical interlead distance (Figure 5) was empha-
sized by Heist and colleagues [24] in a study on 51 consecutive patients referred 
for CRT. The Delta dp/dt value, measured by echo-Doppler, related to acute hemo-
dynamic improvement was correlated with the corrected direct LV-RV horizontal 
interlead tips distance measured on postprocedural lateral radiographs. Acute 
hemodynamic responders to CRT (Delta dP/dt >25%) had higher corrected inter-
lead distance on the lateral film in comparison with non-responders. The interlead 
distance was found to be a useful anatomic parameter to help in guiding the lead 
placement on LV and RV sites in order to optimize CRT outcomes [24].
4.2 Anatomical positioning: segmental pacing site
A commonly used CRT strategy involves the placement of the LV lead in an 
anatomically favorable position [25]. The usually targeted zones for LV lead implant 
are the basal to mid, lateral, or posterolateral LV areas, due to their most delayed 
onset of activation in patients with typical LBBB [25]. There is a general agreement 
that an apical lead position is less favorable [9, 26]. This was also shown in the 
Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization 
Therapy (MADIT-CRT) [27].
Regarding the non-apical positions, the results in the literature are not always 
concordant. The REsynchronization reVErses Remodeling in Systolic Left vEn-
tricular Dysfunction (REVERSE HF) trial revealed better outcomes with lateral 
lead placement [25, 28], while in the Comparison of Medical Therapy, Pacing, and 
Figure 4. 
Over-the-wire advancement of a left ventricular pacing lead into an anterolateral branch of the coronary sinus 
with final placement into a mid-ventricular segment.
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Defibrillation in Heart Failure (COMPANION) trial and MADIT-CRT trial, the 
anterior, lateral, and posterior lead locations had comparable CRT outcomes [1].
Studies focused as well on a standardized anatomical positioning of LV lead 
implant according to its segmentation [12]. In the study by Merchant and colleagues 
[9], event-free survival was significantly lower in the patients with apical LV 
pacing, independent of clinical covariates. The apical group also demonstrated less 
improvement in NYHA functional class and less LV reverse remodeling. These data 
suggest that apical LV lead placement is associated with worse CRT outcomes and 
preferential positioning of LV leads in the basal/midventricle segments would be 
a choice in order to improve the outcomes. These results were also highlighted in a 
substudy analysis of the MADIT-CRT study [25, 29].
These observations have several potential explanations. Firstly, the LV depo-
larization wavefront in most conduction disturbances propagates from the apex to 
midventricle and last to the basal regions of the heart, which are the latest to be 
activated. Secondly, the main CRT objective is to synchronize the ventricles by 
electrical stimulation from RV and LV pacing sites, which ideally should be situ-
ated as far as possible from each other. An apically positioned LV lead is situated 
in the proximity of RV lead which results in reduced inter-electrode distance 
and inter-lead electrical separation, with unfavorable effects on heart failure 
 evolution [18].
Besides anatomic segmental pacing position, shorter AV delays seem to increase 
the efficiency of LV apical pacing, as was shown in the article by Verbeek et al. [19]. 
Working on animal model, they demonstrated that LV function was optimized by 
using AV delays shorter than the baseline PQ time LV and BiV interconnected pac-
ing, by excluding endogenous LV activation so far [18].
4.3 Maximum electrical delay
For an optimal result with cardiac resynchronization, it is necessary to detect the 
latest activated regions of LV, where the pacing lead should be preferably placed, 
resulting in LV hemodynamic improvements [18]. These LV areas of interest could 
be revealed by several invasive and non-invasive imaging techniques. One proposi-
tion was to use the intraprocedural measurement of the LV lead electrical delay 
Figure 5. 
Measurement of the interlead distance on the posteroanterior (PA) and lateral (LL) chest radiograph. 
D = interlead distance; H = horizontal dimension; V = vertical dimension.
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(LVLED), representing the calculated time between onset of the QRS on the surface 
ECG and the sensed signal on the LV lead (Q-LV) (Figure 6).
This delay is corrected for the baseline QRS (recorded simultaneously) by express-
ing it as a percentage of the baseline QRS duration (Q-LV/QRS duration ratio) [10].
Long LV lead electrical delays are linked with LV hemodynamic improvements, 
while shorter than 50% of LV lead electrical delays correlate with a worse clinical 
scenario [10, 18].
Both anatomic interlead separation and the LV electrical delay have been 
correlated with clinical outcomes following CRT in a study of Merchant and col-
leagues [9, 18]. They studied 61 consecutive patients undergoing CRT for standard 
clinical indications and found a positive correlation between corrected LVLED 
and horizontal interlead distance on lateral chest X-ray, and a negative correlation 
between LVLED and vertical interlead distance on posteroanterior chest X-ray 
[9, 18]. That inverse relationship has been transposed in a composite anatomic 
distance (defined as horizontal distance in lateral projection—vertical distance in 
PA projection), which correlated most closely with LVLED. These data suggest that 
LV-right ventricular interlead distance and LVED appear to synergistically combine 
anatomic and electrical parameters for predicting LV anatomic reverse remodeling 
and optimizing them means improving CRT outcomes [9, 18].
A retrospective study of Heist et al. that used a model that included anatomic, 
hemodynamic, and electrical data was able to accurately predict 12-month event-
free survival [30].
Efforts are being made to further define the importance of the electrical delay 
strategy in implanting the LV lead. ENHANCE CRT is a trial that aims to compare 
Figure 6. 
Measurement of the Q-LV interval from the beginning of the QRS complex to the sensed electrogram on the left 
ventricular lead channel.
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LV lead placement based on the electrical delay (Q-LV) with conventional implant 
in patients with non-LBBB [25, 31].
4.4 Maximum mechanical delay
Imaging techniques like tissue-Doppler, strain imaging, two-dimensional speckle-
tracking imaging echocardiography, and tagged magnetic resonance imaging made 
possible identification of the latest activated segments of the LV [3, 6, 32, 33].
In a study on patients with heart failure undergoing CRT, that aimed to delineate 
the effects of CRT on LV performance, Ansalone et al. correlated the LV lead posi-
tion with the site of the most mechanically delayed segment [6]. It was considered 
as concordance between LV pacing site and the most delayed area, when the LV lead 
was implanted in the region with the greatest regional mechanical delay as assessed 
by tissue Doppler. The results revealed that 42% of the patients were paced at a 
concordant site and showed the greatest improvements in clinical status and LV 
performance [3, 6].
A study evaluating the role of speckle-tracking echocardiography, an imag-
ing modality that allows a more precise evaluation of the mechanical activation 
of different LV segments, revealed that LV lead implantation on the site of latest 
mechanical activation provided improvements in echocardiographic response after 
6 months of CRT and better prognosis during long-term follow-up [33, 34].
Another study that assessed the impact of targeted LV lead placement using 
speckle-tracking echocardiography was the randomized targeted left ventricular 
lead placement to guide cardiac resynchronization therapy (TARGET) [35]. In the 
TARGET group of this study, the LV lead was positioned at the latest site of peak 
contraction with amplitude of 10% or greater to signify freedom from scar, while 
in the control group patients underwent standard CRT. When compared with 
controls, TARGET patients had a higher rate of lead concordance (lead placed at the 
most delayed LV segment) and higher rates of clinical response [35].
In the Speckle Tracking Assisted Resynchronization Therapy for Electrode 
Region (STARTER study), the concordance of LV lead with latest site was associ-
ated with an improvement in event-free survival [25, 36].
Summarizing the data available, there is no gold standard defined yet for selec-
tion of the optimal LV pacing segment and determination of the optimal pacing 
site could depend on input from several imaging modalities including image fusion 
strategies [25].
5. Emerging left ventricular pacing strategies
5.1 Endocardial pacing
During the electrical activation of epicardial pacing, the direction of pacing 
impulse is inverted, and that perturbation could become pro-arrhythmic. In this 
respect, endocardial biventricular pacing appears more physiological with the electri-
cal impulse generated from endocardium and dissipated to epicardium [19]. The 
endocardial placement of LV lead is easier and without the restrictions of the coro-
nary venous anatomy. Moreover, phrenic nerve stimulation could be often avoided, 
through the liberty to choose from multiple point LV lead positioning. The compari-
son with epicardial biventricular pacing seems to give encouraging results [19, 37–39].
Jais et al. [39] demonstrated that LV endocardial pacing is feasible. Other 
subsequent reports noticed improvement in clinical and of LV systolic function 
parameters [37, 40–43].
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In an animal study on dogs with experimental LBBB, Van Deursen and col-
leagues [41] used pacing leads positioned in the right atrium, right ventricle, and 
at paired epicardial and endocardial LV sites. The endocardial biventricular pacing 
improved the electrical resynchronization and increased the benefit on LVdP/
dtmax and stroke work by 90 and 50%, respectively, as compared with conventional 
epicardial approach [3]. Endocardial pacing seems not to be associated with the 
significant transmural dispersion of repolarization, often seen in epicardial proce-
dures, and this in turn reduces the arrhythmogenic potential of CRT.
Another study that evaluated endocardial biventricular pacing [42] patients with 
ischemic cardiomyopathy revealed that endocardial biventricular pacing improved 
dP/dt(max) when compared with right ventricular apical pacing in all patients. In 
patients with pre-existing CS leads, LV endocardial pacing at the best endocardial 
site exceeded that achieved with the pre-implanted CRT device (using epicardial 
pacing via the existing CS lead). Optimal pacing sites were found to be located in LV 
segments outside from the postinfarct zone. The findings of this research suggest 
that CRT implanted at the best LV endocardial sites seems to be more effective than 
conventional CS lead epicardial pacing.
There are potential safety issues related to LV endocardial pacing such as 
thromboembolic complications or infection of the endocardial pacing lead [38]. 
Therefore, anticoagulation is required with a proposed international normal-
ized ratio anticoagulation level around 3.5–4.5 (similar to mechanical valvular 
prostheses) [38].
5.2 Multisite and multipoint pacing
Another emerging LV pacing strategy is multisite pacing, which has been 
proposed as an alternative resynchronization strategy aimed at improving clinical 
and echocardiographic outcomes [44]. Triple-site pacing showed improved reverse 
remodeling and heart failure symptoms over a follow-up of 1 year, but implanta-
tion was shown to be difficult and the complication rate was higher than a standard 
approach [3, 45]. The Triple Resynchronization in Paced Heart Failure Patients 
(TRIP-HF) study of Leclercq et al. [44] compared the effects of triple-site versus 
dual-site biventricular pacing in 40 patients diagnosed with moderate-to-severe 
heart failure and permanent atrial fibrillation requiring cardiac pacing for slow 
ventricular rate. The results of this study showed that cardiac resynchronization 
therapy with one RV and two LV leads was associated with significantly more LV 
reverse remodeling than conventional biventricular stimulation.
Quadripolar leads renewed the interest in multipolar pacing. Pacing from 
the most proximal and distal individualized multipoint electrodes could lead to 
improved resynchronization [25, 46]. Multipoint pacing when compared with 
biventricular pacing was shown to be associated with improved ventricular systolic 
and diastolic parameters in an acute hemodynamic study [3, 47].
In a comparison between left ventricular endocardial, multisite, and multipolar 
epicardial pacing, the optimal pacing method was found to be individually specific, 
and on a group level, only endocardial pacing was superior to standard CRT from a 
hemodynamic standpoint [3, 48]. Within individuals, however, different methods 
of stimulation were found to be optimal, suggesting a need to tailor the pacing 
strategy to the underlying substrate [48].
Even though the results of multisite and multipoint pacing were not found 
to be consistently better than the conventional biventricular pacing modality, 
they remain an option for non-responders to conventional CRT, particularly for 
patients who have underlying myocardial scar and a more heterogeneous LV 
activation [49].
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Further studies and prospective trials are warranted to help in identifying the 
subgroups of patients for whom the multisite pacing strategy provides clinical and 
hemodynamical results which are superior to standard CRT.
6. Conclusions
The last two decades have brought a multitude of technical developments in the 
field of CRT. However, the optimal strategy for left ventricular lead positioning, one 
of the most important factors that determine CRT outcomes, continues to remain 
poorly defined.
Anatomical positioning is currently the most frequently used LV lead implant 
strategy; however, several alternative approaches including targeting the most 
electrically or mechanically delayed region of the LV have been shown to be associ-
ated with superior CRT outcomes although the results have been variable. Further 
prospective studies are needed to better define a more reproducible and feasible 
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